Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Novartis building

Novartis licenses tuberculosis R&D to TB Alliance

Includes drugs to tackle resistant forms of the disease

- PMLiVE

UDG sells stake in UniDrug

Alliance Boots will take over full control of supply chain specialist

- PMLiVE

Catalent appoints two board members

Jack Stahl and Rolf Classon to advise drug development, delivery and supply company

- PMLiVE

History rhymes: modern globalisation trends mirror the past

Recent events are an echo of the late 19th century

- PMLiVE

NICE backs Celgene’s Revlimid in bone marrow disorder

Recommends that drug can be used on NHS to treat myelodysplastic syndromes

- PMLiVE

‘Tentative’ US approval for Lilly/Boehringer’s Lantus copy

Full FDA recommendation for insulin is dependent on lawsuit filed by Sanofi

- PMLiVE

Chugai soars on Roche buyout rumours

Reports circulating that Swiss company is poised to make $10bn offer

- PMLiVE

Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

German cost-effectiveness body once again says Fycompa should not be reimbursed

- PMLiVE

How can pharma meet the need for new diabetes drugs in cash-strapped healthcare markets?

Join the Tweetchat on September 25 using hashtag #M3diabetes

Basilea appoints commercial head

David Veitch spent 15 years at BMS

- PMLiVE

Life appoints principal writer

Catriona Hampton joins from Pan

- PMLiVE

AstraZeneca launches diabetes portal in Germany

Zuckerkrank.de is designed to educate patients and families

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links